Montefiore's Institute for Reproductive Medicine and HealthAugust 16, 2021

FDA 483 - Montefiore's Institute for Reproductive Medicine and Health - August 16, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Montefiore's Institute for Reproductive Medicine and Health

Record Details

An FDA inspection of Montefiore's Institute for Reproductive Medicine and Health in Hartsdale, NY, revealed significant deficiencies in donor screening procedures for communicable diseases. The firm failed to adequately screen oocyte and semen donors for Zika virus due to incomplete medical history forms. Additionally, the facility's standard operating procedures and forms for Zika virus donor eligibility were found to be incorrect and not adequately reviewed or revised.

Company: Montefiore's Institute for Reproductive Medicine and Health
Inspection Date: August 16, 2021
Product Type: Biologics
Office: Division of Human and Animal Food Operations - East I
Person: Anthony N. Onianwa (Investigator)

Open in Dashboard

ID · 7078f988-597f-421d-9030-99f50fcd2e0b